| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Marinus Pharmaceuticals Inc (NASDAQ: MRNS)
MRNS Technical Analysis
1.5
| As on 9th Jun 2023 MRNS STOCK Price closed @ 10.42 and we RECOMMEND Buy for LONG-TERM with Stoploss of 7.23 & Sell for SHORT-TERM with Stoploss of 10.49 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MRNSSTOCK Price
| Open | 9.13 | Change | Price | % |
| High | 10.53 | 1 Day | 1.29 | 14.13 |
| Low | 9.03 | 1 Week | 3.31 | 46.55 |
| Close | 10.42 | 1 Month | 2.08 | 24.94 |
| Volume | 1796400 | 1 Year | -0.81 | -7.21 |
| 52 Week High 13.04 | 52 Week Low 3.50 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| MRNS Daily Charts |
MRNS Intraday Charts |
Whats New @ Bazaartrend |
MRNS Free Analysis |
|
|
MRNS Important Levels Intraday
| RESISTANCE | 13.31 |
| RESISTANCE | 12.38 |
| RESISTANCE | 11.81 |
| RESISTANCE | 11.24 |
| SUPPORT | 9.60 |
| SUPPORT | 9.03 |
| SUPPORT | 8.46 |
| SUPPORT | 7.53 |
MRNS Forecast May 2024
| 4th UP Forecast | 16.01 |
| 3rd UP Forecast | 14.22 |
| 2nd UP Forecast | 13.11 |
| 1st UP Forecast | 12 |
| 1st DOWN Forecast | 8.84 |
| 2nd DOWN Forecast | 7.73 |
| 3rd DOWN Forecast | 6.62 |
| 4th DOWN Forecast | 4.83 |
MRNS Weekly Forecast
| 4th UP Forecast | 13.02 |
| 3rd UP Forecast | 12.19 |
| 2nd UP Forecast | 11.67 |
| 1st UP Forecast | 11.16 |
| 1st DOWN Forecast | 9.68 |
| 2nd DOWN Forecast | 9.17 |
| 3rd DOWN Forecast | 8.65 |
| 4th DOWN Forecast | 7.82 |
MRNS Forecast2024
| 4th UP Forecast | 29.09 |
| 3rd UP Forecast | 23.1 |
| 2nd UP Forecast | 19.4 |
| 1st UP Forecast | 15.7 |
| 1st DOWN Forecast | 5.14 |
| 2nd DOWN Forecast | 1.44 |
| 3rd DOWN Forecast | -2.26 |
| 4th DOWN Forecast | -8.25 |
Marinus Pharmaceuticals Inc ( NASDAQ USA Symbol : MRNS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
MRNS Business Profile
Marinus Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on developing and commercializing therapeutics to treat rare seizure disorders. Its clinical stage product candidate, ganaxolone, is an allosteric modulator of GABAA, developed in formulations for two routes, including intravenous (IV) and oral for adult and pediatric patient populations in acute and chronic care, and in-patient and self-administered settings. The company's ganaxolone product candidate, acts at synaptic and extrasynaptic GABAA receptors, a target for its anti-seizure, antidepressant, and anxiolytic potential. It is developing ganaxolone for status epilepticus, cyclin dependent kinase like 5 deficiency disorder, PCDH19-related epilepsy, tuberous sclerosis complex, and postpartum depression. Marinus Pharmaceuticals, Inc. has license agreement with Purdue Neuroscience Company and CyDex Pharmaceuticals, Inc. The company was incorporated in 2003 and is headquartered in Radnor, Pennsylvania. Address: 5 Radnor Corporate Center, Radnor, PA, United States, 19087
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service